Here's why that's BS: By the time glucose tests show abnormalities, you've likely had insulin resistance for years
Well assess if our program is the right fit for you, considering factors like BMI and existing health conditions
Retatrutide remains investigational
If approved, it would likely follow similar criteria as current weight-loss medications: BMI 30 BMI 27 with metabolic conditions Possibly type 2 diabetes Final eligibility would depend on FDA guidelines
Individuals taking GLP-1 receptor agonists should still prioritize protein and fiber intake to maintain muscle mass during weight loss and support long-term metabolic health
The possible mechanisms may involve effects on GLP-1 hormones, the authors of the trial hypothesize, "that are secreted from the gastrointestinal tract and affect appetite by regulating digestive processes and neural signaling in the central nervous system." Medicinal plants are also turning out to be fruitful areas of research